Jiangsu Nanfang Medical (603880) - Total Assets
Based on the latest financial reports, Jiangsu Nanfang Medical (603880) holds total assets worth CN¥912.66 Million CNY (≈ $133.55 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Jiangsu Nanfang Medical cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Jiangsu Nanfang Medical - Total Assets Trend (2012–2025)
This chart illustrates how Jiangsu Nanfang Medical's total assets have evolved over time, based on quarterly financial data. See Jiangsu Nanfang Medical shareholders equity for net asset value and shareholders' equity analysis.
Jiangsu Nanfang Medical - Asset Composition Analysis
Current Asset Composition (December 2025)
Jiangsu Nanfang Medical's total assets of CN¥912.66 Million consist of 34.7% current assets and 65.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 2.8% |
| Accounts Receivable | CN¥114.99 Million | 12.4% |
| Inventory | CN¥138.82 Million | 15.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥40.78 Million | 4.4% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Jiangsu Nanfang Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 603880 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jiangsu Nanfang Medical's current assets represent 34.7% of total assets in 2025, a decrease from 76.9% in 2012.
- Cash Position: Cash and equivalents constituted 2.8% of total assets in 2025, down from 20.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 2.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 15.0% of total assets.
Jiangsu Nanfang Medical Competitors by Total Assets
Key competitors of Jiangsu Nanfang Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.24 Billion |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026
|
China | CN¥1.72 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
Jiangsu Nanfang Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.48 | 0.53 | 1.27 |
| Quick Ratio | 0.31 | 0.30 | 0.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-343.42 Million | CN¥-341.23 Million | CN¥139.32 Million |
Jiangsu Nanfang Medical - Advanced Valuation Insights
This section examines the relationship between Jiangsu Nanfang Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.00 |
| Latest Market Cap to Assets Ratio | 0.34 |
| Asset Growth Rate (YoY) | -12.2% |
| Total Assets | CN¥927.94 Million |
| Market Capitalization | $312.57 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jiangsu Nanfang Medical's assets below their book value (0.34x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Jiangsu Nanfang Medical's assets decreased by 12.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Jiangsu Nanfang Medical (2012–2025)
The table below shows the annual total assets of Jiangsu Nanfang Medical from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥927.94 Million ≈ $135.79 Million |
-12.17% |
| 2024-12-31 | CN¥1.06 Billion ≈ $154.61 Million |
-17.28% |
| 2023-12-31 | CN¥1.28 Billion ≈ $186.91 Million |
-12.35% |
| 2022-12-31 | CN¥1.46 Billion ≈ $213.24 Million |
+17.98% |
| 2021-12-31 | CN¥1.24 Billion ≈ $180.75 Million |
+15.15% |
| 2020-12-31 | CN¥1.07 Billion ≈ $156.96 Million |
+23.35% |
| 2019-12-31 | CN¥869.60 Million ≈ $127.25 Million |
+2.81% |
| 2018-12-31 | CN¥845.81 Million ≈ $123.77 Million |
+2.78% |
| 2017-12-31 | CN¥822.96 Million ≈ $120.43 Million |
+59.32% |
| 2016-12-31 | CN¥516.55 Million ≈ $75.59 Million |
+9.12% |
| 2015-12-31 | CN¥473.37 Million ≈ $69.27 Million |
+8.32% |
| 2014-12-31 | CN¥437.01 Million ≈ $63.95 Million |
+17.05% |
| 2013-12-31 | CN¥373.35 Million ≈ $54.63 Million |
-1.70% |
| 2012-12-31 | CN¥379.79 Million ≈ $55.58 Million |
-- |
About Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical … Read more